Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Julie Goodman to No-Observed-Adverse-Effect Level

This is a "connection" page, showing publications Julie Goodman has written about No-Observed-Adverse-Effect Level.

 
Connection Strength
 
 
 
0.363
 
  1. Prueitt RL, Goodman JE. Evidence evaluated by European Food Safety Authority does not support lowering the temporary tolerable daily intake for bisphenol A. Toxicol Sci. 2024 03 26; 198(2):185-190.
    View in: PubMed
    Score: 0.211
  2. Zu K, Pizzurro DM, Lewandowski TA, Goodman JE. Pharmacokinetic data reduce uncertainty in the acceptable daily intake for benzoic acid and its salts. Regul Toxicol Pharmacol. 2017 Oct; 89:83-94.
    View in: PubMed
    Score: 0.133
  3. Bailey LA, Goodman JE, Beck BD. Proposal for a revised Reference Concentration (RfC) for manganese based on recent epidemiological studies. Regul Toxicol Pharmacol. 2009 Dec; 55(3):330-9.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)